Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 638, Issue 1-2, 2008, Pages 184-194

  Singh, Madhu ^a   Shah, Parag P ^a   Singh, Arvind P ^a   Ruwali, Munindra ^a   Mathur, Neeraj ^a   Pant, Mohan C ^b   Parmar, Devendra ^a  

^a Developmental Toxicology Research Centre   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Alcohol; GST; HNSCC; Polymorphism; Smoking; Tobacco chewing

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS;

NICOTIANA TABACUM;

EID: 37849012005     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.10.003     Document Type: Article

References (51)

1. Indian Council of Medical Research, National Cancer Registry Programme: Biennial report 1988-1989. ICMR, New Delhi, India, 1992.
2. IARC, Pharmaceutical Drugs, IARC monographs on the evaluation of carcinogenic risk of chemicals to humans, vol. 50, International Agency for Research on Cancer, Lyon, France, 415 pp., 1990.
3. Puga A., Nebert D.W., Mckinnon R.A., and Menon A.G. Genetic polymorphisms in human drug-metabolizing enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit. Rev. Toxicol. 27 (1997) 1999-2222
4. Hayes J.D., and Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 (2000) 154-166
5. Geisler S.A., and Olshan A.F. GSTM1, GSTT1 and the risk of squamous cell carcinoma of the head and neck: a mini-review. Am. J. Epidemiol. 154 (2001) 95-105
6. Oude Ophuis M.B., Roelofs H.M.J., van den Brandt P.A., Peters W.H.M., and Manni J.J. Polymorphisms of the glutathione-S-transferase P1 gene and head and neck cancer susceptibility. Head Neck 25 (2003) 37-43
7. Benhamou S., Lee W.J., Alexandrie A.-K., Boffetta P., Bouchardy C., Butkiewicz D., et al. Meta and pooled analyses of the effects of glutathione S-transferases M1 polymorphism and smoking on lung cancer risk. Carcinogenesis 23 (2002) 1343-1350
8. Deakin M., Eldr J., Hendricksen C., Peckham D., Baldwin D., Pantin C., et al. Glutathione-S-transferase GSTT1 genotypes susceptibility to cancer: Studies of interaction with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (Lond.) 17 (1996) 881-884
9. Jourenkova-Mironova N., Rainikainen M., Bouchardy C., Dayer P., Benhamou S., and Hirvonen A. Larynx cancer risk in relation to glutathione-S-transferase M1 & T1 genotypes and tobacco smoking. Cancer Epidem. Biomarkers Prev. 7 (1998) 19-23
10. Cheng L., Sturgis E.M., Eicher S.A., Char D., Spitz M.R., and Wei Q. Glutathione-S-transferase polymorphisms and risk of squamous cell carcinoma of the head and neck. Int. J. Cancer 94 (1999) 220-224
11. Hashibe M., Brennan P., Strange R.C., Bhisey R., Cascorbi I., Lazarus P., Oude Ophuis M.B., Benhamou S., Foulkes W.D., Katoh T., Coutelle C., Romkes M., Gaspari L., Taioli E., and Boffetta P. Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidem. Biomarkers Prev. 12 (2003) 1509-1517
12. Elwood J.M., Pearson J.C., Skippen D.H., and Jackson S.M. Alcohol, smoking, social and occupational factors in the etiology of cancer of the oral cavity, pharynx and larynx. Int. J. cancer 34 (1984) 603-612
13. Eaton D.L., and Bammler T.K. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol. Sci. 49 (1999) 156-164
14. Katoh T., Kaneko S., Kohshi K., Munaka M., Kitagawa K., Kunugita N., lkemura K., and Kawamoto T. Genetic polymorphisms of tobacco and alcohol related metabolizing enzymes and oral cavity cancer. Int. J. Cancer 83 (1999) 606-609
15. Moreno-Lopez L.A., Esparza-Gomez G.C., Gonzalez-Navarro A., Cerero-Lapiedra R., Gonzalez-Hernandez M.J., and Dominguez-Rojas V. Risk of oral cancer associated with tobacco smoking, alcohol consumption and oral hygiene: a case control study in Madrid, Spain. Oral Oncol. 36 (2000) 170-174
16. Blot W.J., McLaughlin J.K., Winn D.M., Austin D.F., Greenberg R.S., Preston-Martin S., Bernstein L., Schoenberg J.B., et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 48 (1988) 3283-3287
17. Peters E.S., McClean M.D., Marsit C.J., Luckett B., and Kelsey K.T. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidem. Biomarkers Prev. 15 (2006) 2196-2202
18. Day G.L., Blot W.J., Austin D.F., Bernstein L., Greenberg R.S., Preston-Martin S., et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco and other determinants. J. Natl. Cancer Inst. 85 (1993) 465-473
19. McWilliams J.E., Evans A.J., Beer T.M., Andersen P.E., Cohen J.I., Everts E.C., and Henner W.D. Genetic polymorphisms in head and neck cancer risk. Head Neck 22 (2000) 609-617
20. Kempkes M., Golka K., Reich S., Reckwitz T., and Bolt H.M. Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch. Toxicol. 71 (1996) 123-126
21. Harries L.W., Stubberns M.J., Forman D., Howard G.C.W., and Wolf C.R. Identification of genetic polymorphisms at the glutathione-S-transferase P1 locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18 (1997) 641-644
22. Olshan A.F., Weissler M.C., Watson M.A., and Bell D.A. GSTM1, GSTT1, GSTP1, CYP1A1 and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidem. Biomarkers Prev. 9 (2000) 185-191
23. Quiñones L., Lucas D., Godoy J., Cáceres D., Berthou F., Varela N., Lee K., Acevedo C., Martínez L., Aguilera A.M., and Gil L. CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett. 174 (2001) 35-44
24. Sikdar N., Mahmud S.K., Paul R.R., and Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett. 195 (2003) 33-42
25. Hung H.C., Chuang J., Chien Y.C., Chern H.D., Chiang C.P., Kuo Y.S., Chen A., and Hildesheim C.J. Genetic polymorphisms of CYP2E1, GSTM1 and GSTT1: Environmental factors and risk of oral cancer. Cancer Epidem. Biomarkers Prev. 6 (1997) 901-905
26. Arand M., Muhlbauer R., Hengstler J., Jager E., Fuchs J., Winkler L., et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem. 236 (1996) 184-186
27. Mishra D.K., Kumar A., Srivastava D.S., and Mittal R.D. Allelic variation of GSTT1, GSTM1 and GSTP1 genes in North Indian population. Asian Pac. J. Cancer Prev. 5 (2004) 362-365
28. Oude Ophuis M.B., Manni J.J., and Peters W.H. Glutathione-S-transferase T1 null polymorphism and the risk for head and neck cancer. Acta Otolaryngol. 126 (2006) 311-317
29. Evans A.J., Henner W.D., Eilers K.M., Montalto M.A., Wersinger E.M., Andersen P.E., Cohen J.I., Everts E.C., McWilliams J.E., and Beer T.M. Polymorphism of GSTT1 and related genes in head and neck cancer risk. Head Neck 26 (2004) 63-70
30. Buch S.C., Notani P.N., and Bhisey R.A. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 23 (2002) 803-807
31. Gronau S., Konig-Greger D., Rettinger G., and Riechelmann H. GSTM1 gene polymorphism in patients with head and neck tumors. Laryngorhinootlogie 79 (2000) 341-344
32. Lin D.X., Tang Y.M., Peng Q., Lu S.X., Ambrosone C.B., and Kadlubar F.F. Susceptibility to esophageal cancer genetic polymorphisms in glutathione-S-transferase T1, P1 and M1 and cytochrome P450 2E1. Cancer Epidem. Biomarkers Prev. 7 (1998) 1013-1018
33. Morita S., Yano M., Tsujinaka T., Ogawa A., Taniguchi M., Kaneko K., Shiozaki H., Doki Y., Inoue M., and Monden M. Association between genetic polymorphisms of glutathione S-transferase P1 and N-acetyltransferase 2 and susceptibility to squamous-cell carcinoma of the oesophagus. Int. J. Cancer (Pred. Oncol.) 79 (1998) 517-520
34. Jain M., Kumar S., Rastogi N., Lal P., Ghoshal U.C., Tiwari A., Pant M.C., Baiq M.Q., and Mittal B. GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett. 242 (2006) 60-67
35. Curran E.J., Stephen R., Weinstein, Lyn R., and Griffiths. Polymorphisms of Glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility. Cancer Lett. 153 (2000) 113-120
36. Matthias C., Bockmühl U., Jahnke V., Harries L.W., Wolf C.R., Jones P.W., Alldersea J., Worrall S.F., Hand P., Fryer A.A., and Strange R.C. The glutathione S-transferase GSTP1 polymorphism: effects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 8 (1998) 1-6
37. Matthias C., Bockmühl U., Jahnke V., Jones P.W., Hayes J.D., Alldersea J., Gilford J., Bailey L., Bath J., Worrall S.F., Hand P., Fryer A.A., and Strange R.C. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione-S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 8 (1998) 91-100
38. Mulder T.P.J., Manni J.J., Roelofs H.M.J., Peters W.H.M., and Wiersma A. Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis 16 (1995) 619-624
39. Saarikoski S.T., Voho A., Reinikainen M., Anttila S., Karjalainen A., Malaveille C., Vainio H., Husgafvel-Pursiainen K., and Hirvonen A. Combined effect of polymorphic GST genes on individual susceptibility to lung cancer. Int. J. Cancer 77 (1998) 516-521
40. Hu X., Xia H., srivastava S.K., Herzog C., Awasthi Y.C., Ji X., et al. Activity of four allelic forms of glutathione-S-transferase hGSTP-1 for epoxides of polycyclic aromatic hydrocarbons. Biochem. Biophys. Res. Commun. 238 (1997) 397-402
41. Nair U.J., Nair J., Mathew B., and Bartsch H. Glutathione S-transferases M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carciongenesis 20 (1999) 743-748
42. Gronau S., Koenig-Greger D., Jerg M., and Riechelmann H. GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral Dis. 9 (2003) 62-67
43. Sharma A., Mishra A., Das B.C., Sardana S., and Sharma J.K. Genetic polymorphism at GSTM1 and GSTT1 gene loci and susceptibility to oral cancer. Neoplasma 53 (2006) 309-315
44. Peters E.S., McClean M.D., Marsit C.J., Luckett B., and Kelsey K.T. Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal and laryngeal carcinoma. Cancer Epidem. Biomarkers Prev. 15 (2006) 2196-2202
45. Vineis P., Bartsch H., Caporaso N., et al. Genetically based N-acetyltransferase metabolic polymorphism and low level environmental exposure to carcinogens. Nature 369 (1994) 154-156
46. Vineis P., and Martone T. Genetic-environmental interactions and low level exposure to carcinogens. Epidemiology 6 (1995) 455-457
47. Lewis S.J., Cherry N.M., Niven R.M., Barber P.V., and Povey A.C. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 180 (2002) 165-171
48. Hamel N., Karimi S., Hebert-Blouin M.N., Brunet J.S., Gilfix B., Ghadirian P., et al. Increased risk of head and neck cancer in association with GSTT1 nullizygosity for individuals with low exposure to tobacco. Int. J. cancer 87 (2000) 452-454
49. Kihara M., Kihara M., Kubota A., Furukawa M., and Kimura H. GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett. 112 (1997) 257-262
50. Park J.Y., Muscat J.E., Ren Q., Schantz S.P., Harwick R.D., Stern J.C., Pike V., Richie Jr. J.P., and Lazarus P. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidem. Biomarkers Prev. 6 (1997) 791-797
51. Ko Y., Abel J., Harth V., Brode P., Antony C., Donat S., Fischer H.-P., Ortiz-Pallardo M.E., Thier R., et al. Association of CYP1B1 Codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue. Cancer Res. 61 (2001) 4398-4404